Innovations in Smart Monitoring Systems - Drug Discovery TOE

USD 950.00

* Required Fields

USD 950.00


Be the first to review this product

This edition of the Drug Discovery TOE discusses life sciences trends across smart monitoring systems, and depict the landscape that is empowering patient’s decisions in the smart devices era. The corresponding patent scenario is illustrated, along with the industry interactions.The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics,

Table of Contents

Innovations in Smart Monitoring Systems - Drug Discovery TOETrend OverviewSmart Monitoring SystemsTechnology ProfilesBiosensor Polymer Technology for Smart Point-of-Care TestingSmartphone Devices for Allergy Treatment MonitoringDigital Microscopic Imaging Solutions for Biotech LabsUltrasonic Technology for Biological Tissue MonitoringNovel Smart Bed Monitoring for Proactive Health MonitoringHealth Monitoring IoT Platform for Personalized CareReal-time PCR-based Molecular Diagnostics for OncologyAppendixPatent AnalysisPatent AnalysisPatent AnalysisIndustry InteractionsIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.